Literature DB >> 499306

Absorption of quinidine from an enteric-coated preparation.

D Fremstad, O G Nilsen, J Amlie, L Storstein, B Olsson, S Jacobsen.   

Abstract

The absorption of quinidine from single and multiple doses of an enteric-coated preparation (Systodin) was studied in seven healthy subjects, and was compared with the pharmacokinetics of intravenously administered quinidine and the results of in vitro dissolution tests of the tablets. Absorption of quinidine began after a variable delay, 2-8 h (mean 4.8) after fasting and 3-10 h (mean 6.1) after food. The rate of absorption varied both in and between individuals. It appeared to be lower when the drug was administered after food. Multiple doses after food gave a pattern of plasma concentration-time curves similar to that found on administration of single doses after food. The delay prior to absorption was prolonged at night. The ratio between the maximum and minimum concentration of quinidine during a dose interval varied from 1.3 to 3.2 (mean 2.0). Bioavailability of quinidine in fasting subjects ranged from 69 to 95% (mean 83); variation was greater when doses were administered after food. The release of quinidine from the enteric-coated preparation was pH dependent and was sustained at low pHs as may be found in the intestines. The results indicate that the absorption of quinidine from the enteric-coated formulation was dependent on the highly variable rate of gastric emptying and the pH of intestinal fluid, and it varied greatly both within and between individuals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 499306     DOI: 10.1007/bf00563116

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration.

Authors:  R E BALL; M SOKOLOW
Journal:  Circulation       Date:  1956-10       Impact factor: 29.690

2.  Concentrations of quinidine in blood following oral, parenteral and rectal administration.

Authors:  E M DITLEFSEN
Journal:  Acta Med Scand       Date:  1953

3.  Studies of plasma quinidine content. III. The value of delayed absorptive coated tablets in oral quinidine therapy.

Authors:  J J SAMPSON; H FOREMAN; B C SOLOMON
Journal:  Circulation       Date:  1952-04       Impact factor: 29.690

4.  Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.

Authors:  G M Frigo; E Perucca; M Teggia-Droghi; G Gatti; A Mussini; J Salerno
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

5.  Dose-dependence of the pharmacokinetics of quinidine.

Authors:  P Bolme; U Otto
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

6.  Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation.

Authors:  G Härtel; A Louhija; A Konttinen; P I Halonen
Journal:  Br Heart J       Date:  1970-01

Review 7.  Drugs, diseases and altered gastric emptying.

Authors:  W S Nimmo
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

8.  Quinidine concentration in serum. The stability during maintained treatment with two different types of delayed absorption tablets.

Authors:  E M Ditlefsen; C Bjerkelund
Journal:  Acta Med Scand       Date:  1966-11

9.  Absolute quinidine bioavailability.

Authors:  C T Ueda; B J Williamson; B S Dzindzio
Journal:  Clin Pharmacol Ther       Date:  1976-09       Impact factor: 6.875

10.  Comparative bioavaiability of four commercial quinidine sulfate tablets.

Authors:  J D Strum; J L Colaizzi; J M Jaffe; P C Martineau; R I Poust
Journal:  J Pharm Sci       Date:  1977-04       Impact factor: 3.534

View more
  3 in total

1.  Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerations.

Authors:  P Mojaverian; P H Vlasses; P E Kellner; M L Rocci
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

2.  Gastrointestinal transit of a solid indigestible capsule as measured by radiotelemetry and dual gamma scintigraphy.

Authors:  P Mojaverian; K Chan; A Desai; V John
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

3.  Gastric emptying of enteric-coated tablets.

Authors:  H M Park; S M Chernish; B D Rosenek; R L Brunelle; B Hargrove; H N Wellman
Journal:  Dig Dis Sci       Date:  1984-03       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.